Identification of a Polyglutamine Protein Aggregation Inhibitor QAI1 and Its Therapeutic Effects on Polyglutamine Neurodegenerative Diseases.

Proceedings for Annual Meeting of The Japanese Pharmacological Society
doi 10.1254/jpssuppl.93.0_2-o-069
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases

Brain Sciences
Neuroscience
2017English

Protein Fate in Neurodegenerative Proteinopathies: Polyglutamine Diseases Join the (Mis)Fold

American Journal of Human Genetics
Genetics
1999English

Intracellular Degradation of Misfolded Proteins in Polyglutamine Neurodegenerative Diseases

Brain Research Reviews
2008English

The Polyglutamine Neurodegenerative Protein Ataxin 3 Regulates Aggresome Formation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Polyglutamine Aggregation Nucleation: Thermodynamics of a Highly Unfavorable Protein Folding Reaction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

TheGinkgo bilobaExtract EGb 761 Modulates Proteasome Activity and Polyglutamine Protein Aggregation

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2014English

Role of Protein Aggregation in Neurodegenerative Diseases

2013English

Extended Polyglutamine Tracts Cause Aggregation and Structural Perturbation of an Adjacent Β Barrel Protein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Pathogenic Mechanisms of a Polyglutamine-Mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy